Recon: Novartis Acquires IFM Subsidiary in $1.6B Deal - Regulatory Focus https://t.co/34Km40mZOz — IDRO (@IDROOhio) April 1, 2019
Recon: Novartis Acquires IFM Subsidiary in $1.6B Deal - Regulatory Focus https://t.co/34Km40mZOz
No comments:
Post a Comment